FR2358144A1 - Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire - Google Patents

Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire

Info

Publication number
FR2358144A1
FR2358144A1 FR7621376A FR7621376A FR2358144A1 FR 2358144 A1 FR2358144 A1 FR 2358144A1 FR 7621376 A FR7621376 A FR 7621376A FR 7621376 A FR7621376 A FR 7621376A FR 2358144 A1 FR2358144 A1 FR 2358144A1
Authority
FR
France
Prior art keywords
compsn
hymecromone
chenodeoxy
treating
lower cost
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7621376A
Other languages
English (en)
Other versions
FR2358144B1 (fr
Inventor
Jean-Claude Lechevin
Jean-Noel Treilles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sante SAS
Original Assignee
LIPHA SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIPHA SAS filed Critical LIPHA SAS
Priority to FR7621376A priority Critical patent/FR2358144A1/fr
Priority to DE19772700085 priority patent/DE2700085A1/de
Priority to NZ184623A priority patent/NZ184623A/xx
Priority to ZA00774164A priority patent/ZA774164B/xx
Priority to IL52502A priority patent/IL52502A/xx
Priority to AU26953/77A priority patent/AU2695377A/en
Priority to BE179283A priority patent/BE856740A/fr
Priority to IE1445/77A priority patent/IE45303B1/en
Priority to JP8307577A priority patent/JPS5312427A/ja
Priority to GB29514/77A priority patent/GB1541165A/en
Publication of FR2358144A1 publication Critical patent/FR2358144A1/fr
Application granted granted Critical
Publication of FR2358144B1 publication Critical patent/FR2358144B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne une nouvelle composition médicamenteuse pour le traitement de la lithiase biliaire. Le principe actif de la composition est constitué par l'association de l'hymécromone (méthyl-4 hydroxy-7 coumarine) et de l'acide chénodésoxycholique. Le médicament est administré par voie orale sous une forme pharmaceutique adaptée.
FR7621376A 1976-07-13 1976-07-13 Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire Granted FR2358144A1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR7621376A FR2358144A1 (fr) 1976-07-13 1976-07-13 Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
DE19772700085 DE2700085A1 (de) 1976-07-13 1977-01-04 Arzneimittel
ZA00774164A ZA774164B (en) 1976-07-13 1977-07-11 Novel medicinal composition for the treatment of biliary lithiasis
IL52502A IL52502A (en) 1976-07-13 1977-07-11 Pharmaceutical compositions for treating bile stones, comprising chenodeoxycholic acid
NZ184623A NZ184623A (en) 1976-07-13 1977-07-11 Pharmaceutical composition for treatment of billiary lithiasis
AU26953/77A AU2695377A (en) 1976-07-13 1977-07-12 Medicinal composition for the treatment of biliary lithiasis
BE179283A BE856740A (fr) 1976-07-13 1977-07-12 Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
IE1445/77A IE45303B1 (en) 1976-07-13 1977-07-12 Composition for treating biliary lithiasis
JP8307577A JPS5312427A (en) 1976-07-13 1977-07-13 Treating agent for galllstone disease
GB29514/77A GB1541165A (en) 1976-07-13 1977-07-13 Composition for treating biliary lithiasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7621376A FR2358144A1 (fr) 1976-07-13 1976-07-13 Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire

Publications (2)

Publication Number Publication Date
FR2358144A1 true FR2358144A1 (fr) 1978-02-10
FR2358144B1 FR2358144B1 (fr) 1978-12-15

Family

ID=9175646

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7621376A Granted FR2358144A1 (fr) 1976-07-13 1976-07-13 Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire

Country Status (4)

Country Link
BE (1) BE856740A (fr)
DE (1) DE2700085A1 (fr)
FR (1) FR2358144A1 (fr)
ZA (1) ZA774164B (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453649A1 (fr) * 1978-12-15 1980-11-07 Lehner Ag Composition pharmaceutique a action prolongee contenant des acides biliaires utile notamment pour la lyse des calculs
EP0065666A1 (fr) * 1981-05-21 1982-12-01 ERREGIERRE S.p.A. Sels des acides choliques, procédé de préparation et compositions thérapeutiques qui les contiennent comme principe actif
EP0509335A1 (fr) * 1991-04-12 1992-10-21 ALFA WASSERMANN S.p.A. Formulations pharmaceutiques gastrorésistantes pour l'administration par voie orale d'acides biliaires
EP0510404A1 (fr) * 1991-04-12 1992-10-28 ALFA WASSERMANN S.p.A. Formulations pharmaceutiques gastrorésistantes pour administration orale contenant des sels d'acides biliaires
WO1994025014A1 (fr) * 1993-04-23 1994-11-10 George Henry Wright Traitement de la cholelithiase avec des beta-2-agonistes

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ211078A (en) * 1984-03-19 1987-08-31 Bristol Myers Co Oral dosage form of etoposide
DE3611467A1 (de) * 1986-04-05 1987-10-08 Dolorgiet Gmbh & Co Kg Hochresorbierbare zubereitungsform des hymecromons und verfahren zur herstellung derselben
AT392906B (de) * 1987-10-08 1991-07-10 Hoffmann La Roche Pharmazeutische praeparate zur oralen verabreichung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453649A1 (fr) * 1978-12-15 1980-11-07 Lehner Ag Composition pharmaceutique a action prolongee contenant des acides biliaires utile notamment pour la lyse des calculs
EP0065666A1 (fr) * 1981-05-21 1982-12-01 ERREGIERRE S.p.A. Sels des acides choliques, procédé de préparation et compositions thérapeutiques qui les contiennent comme principe actif
EP0509335A1 (fr) * 1991-04-12 1992-10-21 ALFA WASSERMANN S.p.A. Formulations pharmaceutiques gastrorésistantes pour l'administration par voie orale d'acides biliaires
EP0510404A1 (fr) * 1991-04-12 1992-10-28 ALFA WASSERMANN S.p.A. Formulations pharmaceutiques gastrorésistantes pour administration orale contenant des sels d'acides biliaires
WO1994025014A1 (fr) * 1993-04-23 1994-11-10 George Henry Wright Traitement de la cholelithiase avec des beta-2-agonistes

Also Published As

Publication number Publication date
ZA774164B (en) 1978-05-30
BE856740A (fr) 1978-01-12
DE2700085A1 (de) 1978-01-26
FR2358144B1 (fr) 1978-12-15

Similar Documents

Publication Publication Date Title
EP0136011A3 (fr) Méthode de traitement hormonal de troubles de la périménopause, ménopause et postménopause et emballage à préparations multiples dans ce but
DE2967049D1 (en) Pharmaceutical and dietary composition comprising gamma-linolenic acids
DE2961102D1 (en) Pharmaceutical and dietary composition comprising gamma-linolenic acids
NO940277L (no) Triglycerider og blandinger av slike
PH14287A (en) Naphthyridine derivatives,pharmaceutical compositions containing same and method of treatment thereof
IL56991A (en) 4-halo-3-oxoandrost-4-ene-17 beta-thiocarboxylic acid esters,their preparation and pharmaceutical compositions containing them
IE801534L (en) Gall-stone dissolution compositions.
FR2358144A1 (fr) Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
PH18822A (en) Sugar containing pharmaceutical preparations having low water content and process fo manufacture
PH13213A (en) Retinoic acid esters of steroids of the pregnone series,their use in the treatment of acne and pharmaceutical formulations useful therefor
AU563273B2 (en) Composition containing an essential fatty acid and niacin and/or a bile salt binder
IL57072A0 (en) 1,3-dibenzoic acid esters of 17 -ethynyl-7 methyl- 1,3,5(10)-oestratrene-1,3,17 -triol and their manufacture and use
FR2377199A2 (fr) Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
ZA784083B (en) Fatty acid and derivatives thereof,and formulations containing them for use in treatment or prophyllaxis of thrombo-embolic conditions
DE3172570D1 (en) Serpentine, alstonine and sempervirine drugs for the specific inhibition of tumurous and cancerous cells
JPS5350316A (en) Drug composition for oral administration
DE3470534D1 (en) Diniflumate of morpholinoethyl ester of niflumic acid, its preparation, and its use in analgesic and antiinflammatory pharmaceutical compositions
PH15995A (en) 1-naphtyl acetic acid derivatives and their therapeutic composition
JPS51139613A (en) An absorbable non-crystalline sterol glycoside monopalmitate ester and a method for preparing its pharmaceutical
EP0222099A3 (fr) Dérivés de l'acide alpha-(amino-alkyl)-aryl acétique
JPS57122068A (en) N-pyrimidinyl-carbamic acid ester, manufacture and medicine containing same
KR880010762A (ko) 소화성궤양의 치료방법 및 치료용 합성물(Composition and Method for Treatment of peptic Ulcers)
ATE36333T1 (de) Hydantoin enthaltende therapeutische mittel.
JPS5255449A (en) Microprocessor
JPS6442470A (en) Guanidinecarboxylic acid esters, manufacture and medicinal composition

Legal Events

Date Code Title Description
ST Notification of lapse